Dataset for The cost of delivering COVID-19 vaccines in Côte d’Ivoire

This study is part of a multi-country research project that utilizes standardized methods to generate cost evidence on the delivery of COVID-19 (C19) vaccines in Vietnam, Bangladesh, and the Philippines in Asia, and Mozambique, Côte d’Ivoire, the Democratic Republic of Congo, and Uganda in Africa. This was a retrospective, bottom-up costing study that estimated the financial and economic costs incurred by Côte d’Ivoire’s public health system to deliver C19 vaccines in 2022. Costs were estimated from a payer perspective, including the Ministry of Health, Public Hygiene and Universal Health Coverage (MOH) and development partners. The study covers the delivery period from March to May 2022, and a start-up period of approximately one month prior to the start of vaccination. Data was collected retrospectively in June 2022 by a team from the Université Felix Houphouet Boigny from a purposively selected sample of 30 health facilities within six districts and three regions (Abidjan 1, Abidjan 2, and Gbêkê), as well as from the national-level MOH and partners. Costs were disaggregated across program activities and resource types to analyze cost drivers. Volume-weighted average unit costs were estimated for each administrative level and then aggregated to obtain the overall volume-weighted cost per dose.